Mirae Asset Global Investments Co., Ltd. Ocular Therapeutix, Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 6,154 shares of OCUL stock, worth $73,478. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,154
Previous 5,261
16.97%
Holding current value
$73,478
Previous $38,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding OCUL
# of Institutions
205Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$171 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$166 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$152 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$138 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$100 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $919M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...